BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32773772)

  • 21. [Constitutional MMR deficiency: Genetic bases and clinical implications].
    Buecher B; Le Mentec M; Doz F; Bourdeaut F; Gauthier-Villars M; Stoppa-Lyonnet D; Colas C
    Bull Cancer; 2019 Feb; 106(2):162-172. PubMed ID: 30551794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
    Ercan AB; Aronson M; Fernandez NR; Chang Y; Levine A; Liu ZA; Negm L; Edwards M; Bianchi V; Stengs L; Chung J; Al-Battashi A; Reschke A; Lion A; Ahmad A; Lassaletta A; Reddy AT; Al-Darraji AF; Shah AC; Van Damme A; Bendel A; Rashid A; Margol AS; Kelly BL; Pencheva B; Heald B; Lemieux-Anglin B; Crooks B; Koschmann C; Gilpin C; Porter CC; Gass D; Samuel D; Ziegler DS; Blumenthal DT; Kuo DJ; Hamideh D; Basel D; Khuong-Quang DA; Stearns D; Opocher E; Carceller F; Baris Feldman H; Toledano H; Winer I; Scheers I; Fedorakova I; Su JM; Vengoechea J; Sterba J; Knipstein J; Hansford JR; Gonzales-Santos JR; Bhatia K; Bielamowicz KJ; Minhas K; Nichols KE; Cole KA; Penney L; Hjort MA; Sabel M; Gil-da-Costa MJ; Murray MJ; Miller M; Blundell ML; Massimino M; Al-Hussaini M; Al-Jadiry MF; Comito MA; Osborn M; Link MP; Zapotocky M; Ghalibafian M; Shaheen N; Mushtaq N; Waespe N; Hijiya N; Fuentes-Bolanos N; Ahmad O; Chamdine O; Roy P; Pichurin PN; Nyman P; Pearlman R; Auer RC; Sukumaran RK; Kebudi R; Dvir R; Raphael R; Elhasid R; McGee RB; Chami R; Noss R; Tanaka R; Raskin S; Sen S; Lindhorst S; Perreault S; Caspi S; Riaz S; Constantini S; Albert S; Chaleff S; Bielack S; Chiaravalli S; Cramer SL; Roy S; Cahn S; Penna S; Hamid SA; Ghafoor T; Imam U; Larouche V; Magimairajan Issai V; Foulkes WD; Lee YY; Nathan PC; Maruvka YE; Greer MC; Durno C; Shlien A; Ertl-Wagner B; Villani A; Malkin D; Hawkins C; Bouffet E; Das A; Tabori U
    Lancet Oncol; 2024 May; 25(5):668-682. PubMed ID: 38552658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofibromatosis type 1: A comparison of the 1997 NIH and the 2021 revised diagnostic criteria in 75 children and adolescents.
    Angelova-Toshkina D; Holzapfel J; Huber S; Schimmel M; Wieczorek D; Gnekow AK; Frühwald MC; Kuhlen M
    Genet Med; 2022 Sep; 24(9):1978-1985. PubMed ID: 35713653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'care for CMMRD' (C4CMMRD).
    Wimmer K; Kratz CP; Vasen HF; Caron O; Colas C; Entz-Werle N; Gerdes AM; Goldberg Y; Ilencikova D; Muleris M; Duval A; Lavoine N; Ruiz-Ponte C; Slavc I; Burkhardt B; Brugieres L;
    J Med Genet; 2014 Jun; 51(6):355-65. PubMed ID: 24737826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive Mutation Analysis of PMS2 in a Large Cohort of Probands Suspected of Lynch Syndrome or Constitutional Mismatch Repair Deficiency Syndrome.
    van der Klift HM; Mensenkamp AR; Drost M; Bik EC; Vos YJ; Gille HJ; Redeker BE; Tiersma Y; Zonneveld JB; García EG; Letteboer TG; Olderode-Berends MJ; van Hest LP; van Os TA; Verhoef S; Wagner A; van Asperen CJ; Ten Broeke SW; Hes FJ; de Wind N; Nielsen M; Devilee P; Ligtenberg MJ; Wijnen JT; Tops CM
    Hum Mutat; 2016 Nov; 37(11):1162-1179. PubMed ID: 27435373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coexistence of Constitutional Mismatch Repair Deficiency syndrome and Lynch syndrome in a family of seven : MSH6 mutation and childhood colorectal cancer - a case series.
    Athanasiadis DI; Athanasiadou KI; Voulgaridou A; Zafeiriou DI; Kattamis A; Christodoulou DK; Papakonstantinou E
    Acta Gastroenterol Belg; 2020; 83(3):479-481. PubMed ID: 33094597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delineating a new feature of constitutional mismatch repair deficiency (CMMRD) syndrome: breast cancer.
    Bush L; Aronson M; Tabori U; Campbell BB; Bedgood RB; Jasperson K
    Fam Cancer; 2019 Jan; 18(1):105-108. PubMed ID: 29785566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer and constitutional Mismatch Repair Deficiency syndrome due to homozygous MSH 6 mutation in children with Café au Lait Spots and review of literature.
    Özyörük D; Cabı EÜ; Taçyıldız N; Pınarlı F; Erdoğan AO; Hanalioğlu Ş; Erdem AY; Demir AM
    Turk J Pediatr; 2021; 63(5):893-902. PubMed ID: 34738371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pitfalls in molecular analysis for mismatch repair deficiency in a family with biallelic pms2 germline mutations.
    Leenen CH; Geurts-Giele WR; Dubbink HJ; Reddingius R; van den Ouweland AM; Tops CM; van de Klift HM; Kuipers EJ; van Leerdam ME; Dinjens WN; Wagner A
    Clin Genet; 2011 Dec; 80(6):558-65. PubMed ID: 21204794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Constitutional mismatch repair deficiency (CMMRD) presenting with high-grade glioma, multiple developmental venous anomalies and malformations of cortical development-a multidisciplinary/multicentre approach and neuroimaging clues to clinching the diagnosis.
    Chhabda S; Sudhakar S; Mankad K; Jorgensen M; Carceller F; Jacques TS; Merve A; Aizpurua M; Chalker J; Garimberti E; D'Arco F
    Childs Nerv Syst; 2021 Jul; 37(7):2375-2379. PubMed ID: 33247381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal Cancer due to Constitutional Mismatch Repair Deficiency Mimicking Neurofibromatosis I.
    Urganci N; Genc DB; Kose G; Onal Z; Vidin OO
    Pediatrics; 2015 Oct; 136(4):e1047-50. PubMed ID: 26391938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel PMS2 alteration c.505C>G (R169G) in trans with a PMS2 pathogenic mutation in a patient with constitutional mismatch repair deficiency.
    Mork ME; Borras E; Taggart MW; Cuddy A; Bannon SA; You YN; Lynch PM; Ramirez PT; Rodriguez-Bigas MA; Vilar E
    Fam Cancer; 2016 Oct; 15(4):587-91. PubMed ID: 27017610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Challenge of Diagnosing Constitutional Mismatch Repair Deficiency Syndrome in Brain Malignancies from Young Individuals.
    Carrato C; Sanz C; Muñoz-Mármol AM; Blanco I; Pineda M; Del Valle J; Dámaso E; Esteller M; Musulen E
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hereditary brain tumor with a homozygous germline mutation in PMS2: pedigree analysis and prenatal screening in a family with constitutional mismatch repair deficiency (CMMRD) syndrome.
    Baig SM; Fatima A; Tariq M; Khan TN; Ali Z; Faheem M; Mahmood H; Killela P; Waitkus M; He Y; Zhao F; Wang S; Jiao Y; Yan H
    Fam Cancer; 2019 Apr; 18(2):261-265. PubMed ID: 30478739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elucidating the clinical significance of two PMS2 missense variants coexisting in a family fulfilling hereditary cancer criteria.
    González-Acosta M; Del Valle J; Navarro M; Thompson BA; Iglesias S; Sanjuan X; Paúles MJ; Padilla N; Fernández A; Cuesta R; Teulé À; Plotz G; Cadiñanos J; de la Cruz X; Balaguer F; Lázaro C; Pineda M; Capellá G
    Fam Cancer; 2017 Oct; 16(4):501-507. PubMed ID: 28365877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome.
    Westdorp H; Kolders S; Hoogerbrugge N; de Vries IJM; Jongmans MCJ; Schreibelt G
    Cancer Lett; 2017 Sep; 403():159-164. PubMed ID: 28645564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD).
    Leenders EKSM; Westdorp H; Brüggemann RJ; Loeffen J; Kratz C; Burn J; Hoogerbrugge N; Jongmans MCJ
    Eur J Hum Genet; 2018 Oct; 26(10):1417-1423. PubMed ID: 29904176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency.
    AlHarbi M; Ali Mobark N; AlMubarak L; Aljelaify R; AlSaeed M; Almutairi A; Alqubaishi F; Hussain ME; Balbaid AAO; Said Marie A; AlSubaie L; AlShieban S; alTassan N; Ramkissoon SH; Abedalthagafi M
    Oncologist; 2018 Dec; 23(12):1401-1406. PubMed ID: 30104292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The great mimicker: Phenotypic overlap between constitutional mismatch repair deficiency and Tuberous Sclerosis complex.
    Shapira Rootman M; Goldberg Y; Cohen R; Kropach N; Keidar I; Friedland R; Dotan G; Konen O; Toledano H
    Clin Genet; 2020 Feb; 97(2):296-304. PubMed ID: 31730237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type.
    Wang Q; Montmain G; Ruano E; Upadhyaya M; Dudley S; Liskay RM; Thibodeau SN; Puisieux A
    Hum Genet; 2003 Feb; 112(2):117-23. PubMed ID: 12522551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.